Senate’s PREVAIL Act Draws Critique Amid Renewed Patent Board Scrutiny

The U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) appears to be under renewed scrutiny with the introduction of the PREVAIL Act, which is slated for Senate markup. Joseph Matal, a former acting director at the USPTO, argues that the criticisms of the PTAB, which began nearly a decade ago, are misguided. According to Matal, these attacks are neither centered around resolving procedural issues nor focused on enhancing the accuracy of patentability decisions. Instead, this ongoing campaign might be driven by motives unrelated to procedural integrity. These insights are detailed in Matal’s analysis as published on Law360.